Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy

Annals of Neurology

Volumn 50, Issue 3, 2001, Pages 381-388

  Nishino, Seiji ^a   Ripley, Beth ^a   Overeem, Sebastiaan ^a,b   Nevsimalova, Sona ^c   Lammers, Gert Jan ^b   Vankova, Jitka ^c   Okun, Michele ^a   Rogers, William ^a   Brooks, Stephen ^a   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; LEPTIN; MUTANT PROTEIN; OREXIN; OREXIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CATAPLEXY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GENE MUTATION; HUMAN; MALE; NARCOLEPSY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; CARRIER PROTEINS; ENERGY METABOLISM; FEMALE; HLA-DQ ANTIGENS; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MIDDLE AGED; NARCOLEPSY; NEUROPEPTIDES;

EID: 0034846670     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1130     Document Type: Article

References (39)

1. Narcolepsy
2. Genetic and familial aspects of narcolepsy
3. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
4. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
5. Neurons containing hypocretin (orexin) project to multiple neuronal systems
6. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
7. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin
8. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
9. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
10. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
11. Hypocretin (orexin) deficiency in human narcolepsy
12. Reduced number of hypocretin neurons in human narcolepsy
13. Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients
14. Increased body-mass index in patients with narcolepsy
15. Central nervous system control of food intake
16. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia
17. Orexin-induced food intake involves neuropeptide Y pathway
18. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats
19. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations
20. Leptin receptor-and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus
21. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus
22. Hypothalamic hypocretin/orexin and neuropeptide Y: Divergent interaction with energy depletion and leptin
23. Validation of a cataplexy questionnaire in 983 sleep disorder patients
24. Psychosocial impact of narcolepsy
25. Life effects of narcolepsy: Measures of negative impact, social support, and psychological well-being
26. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy
27. The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness
28. CSF hypocretin levels in various neurological conditions: Low levels in narcolepsy and Guillian-Barre syndrome
29. Spontaneous food choice in narcolepsy
30. Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched control
31. Circadian distribution of motor activity and immobility in narcolepsy
32. Nighttime and daytime urinary excretion of MHPG-SO4 in narcoleptic and controls
33. Circadian temperature and activity rhythms in unmedicated narcolepsy patients
34. Autonomic control of cardiovascular reflexes in narcolepsy
35. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance